The diagnostic accuracy and safety have been demonstrated of a non-invasive brush biopsy of visible oral lesions analysed with cytology analysis in the FA population. This was a large prospective study carried out in Germany by Heinrich Heine University together with the German support group (Fanconi Hilfe).
Based on these findings that oral cancer can be detected earlier than the current standard of care, the special “Add-on Screening for oral cancer screening in patients with Fanconi anemia using brush biopsy” was developed and is being trialed in Australia and New Zealand.
If you would like your doctor to start using this add-on screening, please contact research@fasa.org.au
